The Yale Comprehensive Section of Gynecologic Oncology is a team of clinicians whose focus is caring for women with gynecologic cancer.
Our doctors are board-certified in obstetrics and gynecology, as well as in the subspecialty of gynecologic oncology: the management of patients with gynecological cancer through a combination of surgery, chemotherapy and radiation therapy.
- Learn more about our services
The Section is a key component of the Yale Cancer Center, the only National Cancer Institute-designated research center in Southern New England. Section members play a vital role in introducing new methods of treating and diagnosing gynecologic cancers. For example, Yale offers the only program in the state for the early detection of ovarian cancer and has developed the use of chemotherapy prior to surgery (neoadjuvant chemotherapy) in managing advanced-stage ovarian cancer.
Patients’ cases are reviewed in weekly conferences by physicians from many disciplines, including medical oncology, therapeutic radiology, pathology and gynecologic oncology. This multidisciplinary approach helps ensure that patients receive the most beneficial course of treatment.
The Section of Gynecologic Oncology runs a 28-bed inpatient unit in the new West Pavilion of the Yale-New Haven Hospital and an outpatient treatment area.
Both inpatient and outpatient facilities are staffed with nurses whose specialty is caring for patients with gynecologic cancer. Our inpatient unit recently received the highest score in a patient satisfaction survey conducted at the Yale-New Haven Hospital.